Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA A Cancer J Clin 71(3):209–249. https://doi.org/10.3322/caac.21660
International Agency for Research on Cancer. Global cancer observatory: cancer today. Available online: https://gco.iarc.fr/today/online-analysis-table. (accessed on 11 October 2022)
Stewart BW, Wild CP (2014) World Cancer Report 2014. International Agency for Research on Cancer, France. http://www.esmo.org/Oncology-News/World-Cancer-Report-2014
Li T, Chai P, Zhang Y, Wan Q, Zhai T, Guo F, Li Y, Wang R, Chen C, Liu G (2021) Analysis of Cost Accounting and Financing Burden of Tumor Treatment in China. Health Econ Res 38(07):17–20 in Chinese
Huang HY, Shi JF, Guo LW, Bai YN, Liao XZ, Liu GX, Mao AY, Ren JS, Sun XJ, Zhu XY, Wang L, Song BB, Du LB, Zhu L, Gong JY, Zhou Q, Liu YQ, Cao R, Mai L, Lan L, Sun XH, Ren Y, Zhou JY, Wang YZ, Qi X, Lou PA, Shi D, Li N, Zhang K, He J, Dai M (2017) Expenditure and financial burden for the diagnosis and treatment of colorectal cancer in China: a hospital-based, multicenter, cross-sectional survey. Chin J Cancer 36(1):41. https://doi.org/10.1186/s40880-017-0209-4
Article PubMed PubMed Central Google Scholar
Sui M, Zeng X, Tan WJ, Tao S, Liu R, Liu B, Ma W, Huang W, Yu H (2020) Catastrophic health expenditures of households living with pediatric leukemia in China. Cancer Med 9(18):6802–6812. https://doi.org/10.1002/cam4.3317
Article PubMed PubMed Central Google Scholar
Al-Rabayah AA, Al Froukh RF, Al Najjar B, Rayyan M, Salmany S, Iweir S, Nazer L (2022) Quality of Life of Family Caregivers of Critically Ill Patients With Cancer Before and After Intensive Care Unit Admission Measured by EQ-5D 3-Level: A Longitudinal Prospective Cohort Study. Value Health Reg Issues 30:39–47. https://doi.org/10.1016/j.vhri.2021.11.003
Lakha F, Suriyawongpaisul P, Sangrajrang S, Leerapan B, Coker R (2020) Breast cancer in Thailand: policy and health system challenges to universal healthcare. Health Policy Plan 35(9):1159–1167. https://doi.org/10.1093/heapol/czaa063
Anderson B (2016) Cancer management: the difficulties of a target-driven healthcare system. Br J Nurs (Mark Allen Publishing) 25(9):S36–S40. https://doi.org/10.12968/bjon.2016.25.9.S36
American Cancer Society. What is a cancer caregiver? Online. https://www.cancer.org/treatment/caregivers/what-a-caregiver-does/who-and-what-are-caregivers.html. (accessed on 31 October 2023).
Kilic ST, Oz F (2019) Family Caregivers’ Involvement in Caring with Cancer and their Quality of Life. Asian Pac J Cancer Prev: APJCP 20(6):1735–1741. https://doi.org/10.31557/APJCP.2019.20.6.1735
Article PubMed PubMed Central Google Scholar
Unsar S, Erol O, Ozdemir O (2021) Caregiving burden, depression, and anxiety in family caregivers of patients with cancer. Eur J Oncol Nurs 50:101882. https://doi.org/10.1016/j.ejon.2020.101882
Lim J, Cho H, Bunds KS, Lee CW (2021) Cancer family caregivers’ quality of life and the meaning of leisure. Health Care Women Int 42(7–9):1144–1164. https://doi.org/10.1080/07399332.2020.1752214
Robinson R (1993) Cost-utility analysis. BMJ 307(6908):859–862. https://doi.org/10.1136/bmj.307.6908.859
Article CAS PubMed PubMed Central Google Scholar
Drummond MF, Schwartz JS, Jonsson B, Luce BR, Neumann PJ, Siebert U, Sullivan SD (2008) Key principles for the improved conduct of health technology assessments for resource allocation decisions. Int J Technol Assess Health Care 24(3):244–368. https://doi.org/10.1017/S0266462308080343
EuroQol Group (1990) EuroQol–a new facility for the measurement of health-related quality of life. Health Policy (Amsterdam, Netherlands) 16(3):199–208. https://doi.org/10.1016/0168-8510(90)90421-9
Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D, Bonsel G, Badia X (2011) Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res 20(10):1727–1736. https://doi.org/10.1007/s11136-011-9903-x
Article CAS PubMed PubMed Central Google Scholar
Rawlins MD, Culyer AJ (2004) National Institute for Clinical Excellence and its value judgments. BMJ (Clin Res ed) 329(7459):224–227. https://doi.org/10.1136/bmj.329.7459.224
Devlin NJ, Brooks R (2017) EQ-5D and the EuroQol Group: Past, Present and Future. Appl Health Econ Health Policy 15(2):127–137. https://doi.org/10.1007/s40258-017-0310-5
Article PubMed PubMed Central Google Scholar
Li L, Liu C, Cai X, Yu H, Zeng X, Sui M, Zheng E, Li Y, Xu J, Zhou J, Huang W (2019) Validity and reliability of the EQ-5D-5L in family caregivers of leukemia patients. BMC Cancer 19(1):522. https://doi.org/10.1186/s12885-019-5721-2
Article CAS PubMed PubMed Central Google Scholar
Yu H, Zeng X, Sui M, Liu R, Tan RL, Yang J, Huang W, Luo N (2021) A head-to-head comparison of measurement properties of the EQ-5D-3L and EQ-5D-5L in acute myeloid leukemia patients. Qual Life Res 30(3):855–866. https://doi.org/10.1007/s11136-020-02644-w
Scalone L, Ciampichini R, Fagiuoli S, Gardini I, Fusco F, Gaeta L, Del Prete A, Cesana G, Mantovani LG (2013) Comparing the performance of the standard EQ-5D 3L with the new version EQ-5D 5L in patients with chronic hepatic diseases. Qual Life Res 22(7):1707–1716. https://doi.org/10.1007/s11136-012-0318-0
Janssen MF, Birnie E, Haagsma JA, Bonsel GJ (2008) Comparing the standard EQ-5D three-level system with a five-level version. Value Health 11(2):275–284. https://doi.org/10.1111/j.1524-4733.2007.00230.x
Liu GG, Wu H, Li M, Gao C, Luo N (2014) Chinese time trade-off values for EQ-5D health states. Value Health 17(5):597–604. https://doi.org/10.1016/j.jval.2014.05.007
Luo N, Liu G, Li M, Guan H, Jin X, Rand-Hendriksen K (2017) Estimating an EQ-5D-5L Value Set for China. Value Health 20(4):662–669. https://doi.org/10.1016/j.jval.2016.11.016
Brazier J, Roberts J, Deverill M (2002) The estimation of a preference-based measure of health from the SF-36. J Health Econ 21(2):271–292. https://doi.org/10.1016/s0167-6296(01)00130-8
Sun CY, Liu Y, Zhou LR, Wang MS, Zhao XM, Huang WD, Liu GX, Zhang X (2021) Comparison of EuroQol-5D-3L and Short Form-6D Utility Scores in Family Caregivers of Colorectal Cancer Patients: A Cross-Sectional Survey in China. Front Public Health 9:742332. https://doi.org/10.3389/fpubh.2021.742332
Article PubMed PubMed Central Google Scholar
Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5(6):649–655
Article CAS PubMed Google Scholar
Ware JE Jr, Sherbourne CD (1992) The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30(6):473–483
Hott A, Liavaag S, Juel NG, Brox JI, Ekeberg OM (2021) The reliability, validity, interpretability, and responsiveness of the Norwegian version of the Anterior Knee Pain Scale in patellofemoral pain. Disabil Rehabil 43(11):1605–1614. https://doi.org/10.1080/09638288.2019.1671499
Pickard AS, De Leon MC, Kohlmann T, Cella D, Rosenbloom S (2007) Psychometric comparison of the standard EQ-5D to a 5 level version in cancer patients. Med Care 45(3):259–263. https://doi.org/10.1097/01.mlr.0000254515.63841.81
Terwee CB, Bot SD, de Boer MR, van der Windt DA, Knol DL, Dekker J, Bouter LM, de Vet HC (2007) Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol 60(1):34–42. https://doi.org/10.1016/j.jclinepi.2006.03.012
Cohen J (1988) Chi-square tests for goodness of fit and contingency tables. Stat Power Anal Behav Sci 2:215–271
Yfantopoulos JN, Chantzaras AE (2017) Validation and comparison of the psychometric properties of the EQ-5D-3L and EQ-5D-5L instruments in Greece. Eur J Health Economics 18(4):519–531. https://doi.org/10.1007/s10198-016-0807-0
Janssen MF, Bonsel GJ, Luo N (2018) Is EQ-5D-5L Better Than EQ-5D-3L? A Head-to-Head Comparison of Descriptive Systems and Value Sets from Seven Countries. Pharmacoeconomics 36(6):675–697. https://doi.org/10.1007/s40273-018-0623-8
Article PubMed PubMed Central Google Scholar
Pickard AS, Ray S, Ganguli A, Cella D (2012) Comparison of FACT- and EQ-5D-based utility scores in cancer. Value Health 15(2):305–311. https://doi.org/10.1016/j.jval.2011.11.029
Huang IC, Willke RJ, Atkinson MJ, Lenderking WR, Frangakis C, Wu AW (2007) US and UK versions of the EQ-5D preference weights: does choice of preference weights make a difference? Qual Life Res 16(6):1065–1072. https://doi.org/10.1007/s11136-007-9206-4
Hays RD, Anderson R, Revicki D (1993) Psychometric considerations in evaluating health-related quality of life measures. Qual Life Res 2(6):441–449. https://doi.org/10.1007/BF00422218
Comments (0)